Franklin Resources’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-96,400
Closed -$1.05M 1560
2019
Q3
$1.05M Sell
96,400
-1,420,052
-94% -$15.5M ﹤0.01% 1263
2019
Q2
$14.2M Sell
1,516,452
-1,199,048
-44% -$12.1M 0.01% 825
2019
Q1
$33.3M Hold
2,715,500
0.02% 618
2018
Q4
$32.2M Hold
2,715,500
0.02% 582
2018
Q3
$39.1M Hold
2,715,500
0.02% 594
2018
Q2
$40.5M Hold
2,715,500
0.02% 592
2018
Q1
$35.4M Hold
2,715,500
0.02% 621
2017
Q4
$34.2M Hold
2,715,500
0.02% 640
2017
Q3
$35.2M Sell
2,715,500
-24,800
-0.9% -$327K 0.02% 635
2017
Q2
$40.7M Sell
2,740,300
-106,900
-4% -$1.49M 0.02% 588
2017
Q1
$34.2M Hold
2,847,200
0.02% 637
2016
Q4
$39.3M Hold
2,847,200
0.02% 590
2016
Q3
$38.2M Hold
2,847,200
0.02% 609
2016
Q2
$30.6M Buy
2,847,200
+706,400
+33% +$7.79M 0.02% 676
2016
Q1
$22.5M Buy
2,140,800
+1,119,000
+110% +$12.3M 0.01% 785
2015
Q4
$12.1M Buy
+1,021,800
New +$12.5M 0.01% 966

Other funds holding LFCR

Franklin Resources's LFCR Position: Q4 2019 in Review

Franklin Resources sold out of Lifecore Biomedical (LFCR) in Q4 2019, closing a stake of 96,400 shares — an estimated $1.05M sold.

Franklin Resources first reported a position in LFCR in Q4 2015 and held it in 16 quarters. The position peaked at $40.7M in Q2 2017. 93 funds tracked by Wall St. Rank hold LFCR as of Q4 2019.

  • Franklin Resources reported no remaining Lifecore Biomedical position as of Q4 2019 after selling out during the quarter.
  • Franklin Resources sold 96,400 Lifecore Biomedical shares in Q4 2019, an estimated $1.05M.
  • Franklin Resources first reported a position in Lifecore Biomedical in Q4 2015 and held it in 16 quarters.
  • Franklin Resources's Lifecore Biomedical position peaked at $40.7M in Q2 2017.
  • 93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2019.

Based on Franklin Resources's 13F filing for Q4 2019, filed 12 Feb 2020.